Effect of Chronic Treatment with Angiotensin I Converting Enzyme Inhibitors on Circulating Atrial Natriuretic Polypeptide in Spontaneously Hypertensive Rats
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 9 (2-3) , 693-696
- https://doi.org/10.3109/10641968709164244
Abstract
We have recently shown that circulating atrial natriuretic polypeptide (ANP) in adult spontaneously hypertensive rats (SHR) is higher than that in age-matched Wistar-Kyoto rats (WKY). The present experiment was designed to examine the possible effects of chronic treatment with angiotensin I converting enzyme inhibitors (ACEI) on plasma ANP levels in SHR. Captopril and enalapril lowered blood pressure and reduced relative ventricular weight in SHR but not to the level of WKY. Plasma ANP levels were decreased by captopril and enalapril compared with untreated SHR. These results suggest that the ANP release may be suppressed in ACEI-treated SHR compared with untreated SHR. We speculate that a reduction of cardiac overload by ACEI may in part explain the decline of circulating ANP.Keywords
This publication has 4 references indexed in Scilit:
- An Accelerated Increase of Circulating Atrial Natriuretic Polypeptide in Salt-Loaded Spontaneously Hypertensive RatsHormone and Metabolic Research, 1986
- Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidismBiochemical and Biophysical Research Communications, 1986
- Vasopressin-Stimulated Release of Atriopeptin: Endocrine Antagonists in Fluid HomeostasisScience, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981